Annexin-1 is abnormally expressed in fragile X syndrome: Two-dimensional electrophoresis study in lymphocytes

American Journal of Medical Genetics

Volumn 103, Issue 1, 2001, Pages 81-90

  Sun, Hong Tao ^a,b   Cohen, Sonia ^b   Kaufmann, Walter E ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

2D PAGE; Annexin 1; FMR1; FMRP; Fragile X; Leukocytes

Indexed keywords

GENE PRODUCT; PROTEIN FMRP; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CLINICAL ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; FEMALE; FRAGILE X SYNDROME; GEL ELECTROPHORESIS; GENE MUTATION; HUMAN; IMMUNOREACTIVITY; LYMPHOCYTE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ADOLESCENT; ADULT; ANNEXIN A1; CHILD; CHILD, PRESCHOOL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; IMMUNOBLOTTING; LYMPHOCYTES; MALE; MUTATION; NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS;

EID: 0035885312     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8628(20010915)103:1<81::AID-AJMG1505>3.0.CO;2-T     Document Type: Article

References (55)

1. The annexin protein lipocortin 1 regulates the MAPK/ERK pathway
2. A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein
3. A distinct FMRP polysomal population at an advanced stage of mammalian erythropoiesis
4. Regulation of microtubule composition and stability during nerve growth factor-promoted neurite outgrowth
5. Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex
6. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation
7. Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus
8. Specific interaction between a subset of the p53 protein family and heat shock proteins hsp72/hsc73 in a human osteosarcoma cell line
9. An approach to proteomic analysis of human tumors
10. Annexin-1 localization in human skin: Possible association with cytoskeletal elements in keratinocytes of the stratum spinosum
11. Quantitative comparison of FMRI gene expression in normal and premutation alleles
12. Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome
13. High functioning fragile X males: Demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression
14. Mass spectrometric and Edman sequencing of lipocortin I isolated by two-dimensional SDS/PAGE of human melanoma lysates
15. Two-dimensional electrophoresis resources available from ExPASy
16. Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis
17. Understanding the molecular basis of fragile X syndrome
18. Dendritic anomalies in disorders associated with mental retardation
19. Molecular and cellular genetics of fragile X syndrome
20. Cox-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex
21. Immunoblotting patterns of cytoskeletal dendritic protein expression in human neocortex
22. FMR protein isoform quantitation: A complementary diagnostic assay for fragile X syndrome
23. Genotype, molecular phenotype, and cognitive phenotype: Correlations in fragile X syndrome
24. Dendritic cytoskeletal protein expression in mental retardation: An immunohistochemical study of the neocortex in Rett syndrome
25. Biology of the fragile X mental retardation protein, an RNA-binding protein
26. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2
27. S100-annexin complexes: Some insights from structural studies
28. Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level
29. Microglia, astrocytes, and macrophages react differentially to central and peripheral lesions in the developing and mature rat whisker-to-barrel pathway: A study using immunohistochemistry for lipocortin1, phosphotyrosine, s100 beta, and mannose receptors
30. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I
31. Neurotrophic action of lipocortin 1 derived from astrocytes on cultured rat cortical neurons
32. Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in Vacutainer CPT and standard Vacutainer tubes
33. Differential expression of annexins I-VI in the rat dorsal root ganglia and spinal cord
34. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome
35. Complex behavior of simple repeats: The fragile X syndrome
36. Glucocorticoids modulate the cellular disposition of lipocortin 1 in the rat brain in vivo and in vitro
37. Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes
38. Structural basis of the Ca(2+)-dependent association between S100C (S100A11) and its target, the N-terminal part of annexin I
39. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: The first 2,253 cases
40. Prevalence of carriers of premutation-size alleles of the FMR1 gene an implications for the population genetics of the fragile X syndrome
41. Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts
42. Microglia and astrocytes in the adult rat brain: Comparative immunocytochemical analysis demonstrates the efficacy of lipocortin 1 immunoreactivity
43. Mapping and identification of interferon gamma-regulated HeLa cell proteins separated by immobilized pH gradient two-dimensional gel electrophoresis
44. FXR1, an autosomal homolog of the fragile X mental retardation gene
45. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ
46. A novel de novo mutation in the desmin gene causes desmin myopathy with toxic aggregates
47. RNAs that interact with the fragile X syndrome RNA binding protein FMRP
48. Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P
49. Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations
50. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
51. Expression of annexin and annexin-mRNA in rat brain under influence of steroid drugs
52. Cortisol and social stressors in children with fragile X: A pilot study
53. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2
54. Ca(2+)-dependent inhibition of actin-activated myosin ATPase activity by S100C (S100A11), a novel member of the S100 protein family
55. Reduced mRNA for G3BP in fragile X cells: Evidence of FMR1 gene regulation